Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Early Diagnosis of Multidrug-Resistant Pneumonia Benefits Patient Outcomes

SEP 12, 2017 | CONTAGION® EDITORIAL STAFF


Alan Gross, PharmD, BCPS-AQID, Clinical Assistant Professor, Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, shares how early diagnosis of multidrug-resistant pneumonia can improve patient outcomes. With early diagnosis, health care providers can avoid using broad-spectrum antibiotics and prove a more effective targeted treatment.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
NIAID researchers make an unexpected discovery when examining how a cellular enzyme complex regulates herpesvirus; inhibiting the enzyme suppressed viral infection.
x